Fiji Kava Limited (ASX:FIJ) advises that as per the previously announced partnership with IMCD-Network Nutrition, tranche 2 of investment by principal Ryan Gorman has been completed - being 1,000,000 shares priced at 12c and 1,000,000 options priced at 0.5c.
Fiji Kava Limited (ASX:FIJ) has seen a significant uplift on sales performance in Q3 FY22. In the interests of maintaining an informed market, FIJ provides the following preliminary estimates for sales and cash flows for the quarter ended March 31st 2022.
VGI Health Technology Limited (NSX:VTL) is pleased to announce that it has today executed a binding agreement for the sale of its wholly owned subsidiary Invictus BioPharma Pty Ltd.
VGI Health Technology Limited (NSX:VTL) is pleased to announce that the United States Patent and Trademarks Office (USPTO) intends to grant a divisional patent for the 'Transmucosal Delivery of Tocotrienols' to its wholly-owned subsidiary Invictus Biotechnology Pty Ltd.
Fiji Kava Limited (FIJ.AX) continues to drive awareness of Fijian Noble Kava to support growth through marketing initiatives.
VGI Health Technology Limited (NSX:VTL) is pleased to announce that Dr Jordan Moon, a member of its Scientific Advisory Board, will be presenting an abstract at the American Society for Nutrition (ASN) Annual Conference, Nutrition 2022.
Fiji Kava Ltd (ASX:FIJ) has today announced an investment by BSP Life (Fiji) Ltd totalling 2 million FJD via the purchase of Convertible Notes.
